Biolase (BIOL) Appoints Kathleen T. O'Loughlin, Carol Gomez Summerhays, and Martha Somerman to its Board

Go back to Biolase (BIOL) Appoints Kathleen T. O'Loughlin, Carol Gomez Summerhays, and Martha Somerman to its Board

Biolase (BIOL) Tops Q2 EPS by 4c

August 12, 2021 4:29 PM EDT

Biolase (NASDAQ: BIOL) reported Q2 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.31 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

... More